Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Buscombe

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Anticancer Research|September 3, 1999
Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancerJ B Cwikla, J R Buscombe, A D Kolasinska, et al.
Nuclear Medicine Review. Central & Eastern Europe|November 6, 2003
Comparison of functional imaging and standard CT in evaluation of disease extent in patients with tumours showing neuroendocrine featuresJ B Cwikła, J R Buscombe, W A Mielcarek, et al.
Nuclear Medicine Review. Central & Eastern Europe|November 6, 2003
The role of scintimammography and mammography in recurrent breast cancer. Evaluation of their accuracy using ROC curvesA D Kolasińska, J R Buscombe, J B Cwikła, et al.
Alimentary Pharmacology & Therapeutics|February 4, 2003
Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid syndrome: a 3-year experienceJ Garland, J R Buscombe, C Bouvier, et al.
The British Journal of Surgery|May 1, 1997
Prospective study of hepatobiliary scintigraphy and endoscopic cholangiography for the detection of early biliary complications after orthotopic liver transplantationT R Kurzawinski, L Selves, M Farouk, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 15, 2002
The clinical application of a dual head gamma camera with coincidence detection in 20 women with suspected ovarian cancerG Lieberman, A B MacLean, J R Buscombe, et al.
Nuclear Medicine Communications|August 1, 1994
Clinical experience with a multidetector SPET system (Toshiba GCA-9300A)S Mahmood, J R Buscombe, K Kouris, et al.
Nuclear Medicine Communications|March 16, 2000
Toxicity of high-activity 111In-Octreotide therapy in patients with disseminated neuroendocrine tumoursM E Caplin, W Mielcarek, J R Buscombe, et al.
Nuclear Medicine Communications|December 16, 1998
Use of 99Tcm-MIBI in the assessment of patients with suspected recurrent breast cancerJ B Cwikla, J R Buscombe, S P Parbhoo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2009
Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II studyJ B Cwikla, A Sankowski, N Seklecka, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Anticancer Research|September 3, 1999
Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancerJ B Cwikla, J R Buscombe, A D Kolasinska, et al.
Nuclear Medicine Review. Central & Eastern Europe|November 6, 2003
Comparison of functional imaging and standard CT in evaluation of disease extent in patients with tumours showing neuroendocrine featuresJ B Cwikła, J R Buscombe, W A Mielcarek, et al.
Nuclear Medicine Review. Central & Eastern Europe|November 6, 2003
The role of scintimammography and mammography in recurrent breast cancer. Evaluation of their accuracy using ROC curvesA D Kolasińska, J R Buscombe, J B Cwikła, et al.
Alimentary Pharmacology & Therapeutics|February 4, 2003
Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid syndrome: a 3-year experienceJ Garland, J R Buscombe, C Bouvier, et al.
The British Journal of Surgery|May 1, 1997
Prospective study of hepatobiliary scintigraphy and endoscopic cholangiography for the detection of early biliary complications after orthotopic liver transplantationT R Kurzawinski, L Selves, M Farouk, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 15, 2002
The clinical application of a dual head gamma camera with coincidence detection in 20 women with suspected ovarian cancerG Lieberman, A B MacLean, J R Buscombe, et al.
Nuclear Medicine Communications|August 1, 1994
Clinical experience with a multidetector SPET system (Toshiba GCA-9300A)S Mahmood, J R Buscombe, K Kouris, et al.
Nuclear Medicine Communications|March 16, 2000
Toxicity of high-activity 111In-Octreotide therapy in patients with disseminated neuroendocrine tumoursM E Caplin, W Mielcarek, J R Buscombe, et al.
Nuclear Medicine Communications|December 16, 1998
Use of 99Tcm-MIBI in the assessment of patients with suspected recurrent breast cancerJ B Cwikla, J R Buscombe, S P Parbhoo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2009
Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II studyJ B Cwikla, A Sankowski, N Seklecka, et al.
Pageof 8